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Background
Increased cancer risk has been well established in sev-
eral HIV-infected populations. However, studies investi-
gating mortality after a diagnosis of cancer have been
limited in size, scope, and HIV-specific risk factors.
Materials and methods
CNICS is a cohort of over 20,000 HIV-infected adults in
clinical care at eight U.S. sites. We included patients
with chart review verified incident cancer diagnoses
between 1996 and 2009. Non-AIDS defining cancers
(NADC) were categorized as infection (HPV, EBV, or
HBV/HCV)-related [1]: squamous cell anal, squamous
cell oral cavity/pharynx, penis, vagina/vulva, Hodgkins,
and liver; or non-infection-related: all other NADCs.
Death was confirmed by the National Death Index and/
or state death certificate data. We examined indepen-
dent predictors of mortality by employing Cox propor-
tional hazards regression models.
Results
918 adults with HIV and cancer were included in this
analysis. 55% had AIDS-defining cancer (ADC), 15% had
infection-related NADC, and 30% had non-infection
related NADC. At cancer diagnosis, median age was 43
years, 50% were white, 86% male, 19% IDU, 21% HBV/
HCV, 46% current smokers, and 56% current alcohol
drinkers. Median CD4+ cell count was 192 cells/mm
3
and HIV RNA was 3.6 log10 copies/ml. There were 395
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Table 1
Mortality Hazard
Ratio*
95%
Confidence
Limits
Age, per 10 years 1.23 1.09, 1.40
White 0.77 0.62, 0.95
Male 1.06 0.78, 1.44
HBV/HCV 1.11 0.86, 1.43
IDU 1.31 1.00, 1.70
Smoking:
Never 1 -
Former 1.51 1.08, 2.12
Current 1.45 1.04, 2.02
Alcohol intake:
Never 1 -
Former 0.99 0.72, 1.36
Current 0.78 0.58,1.04
HIV RNA, per log10
copies/ml 1.09 1.01, 1.17
CD4 count:
> 500 cells/mm
3 1-
200–500 cells/mm
3 1.11 0.77, 1.59
< 200 cells/mm
3 1.57 1.10, 2.26
Summary cancer
type:
ADC 1 -
Infection-related
NADC 0.78 0.55, 1.11
Non-infection-
related NADC 1.38 1.05, 1.82
*Adjusted for all variables in the table.
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© 2010 Achenbach et al; licensee BioMed Central Ltd.deaths in 2,393 person-years of follow-up for a crude
mortality rate of 16.5 per 100 person-years (95% CL:
15.0, 18.2). Adjusted hazard of mortality was signifi-
cantly increased among individuals who were older,
non-white, IDU, current or former smokers, had lower
CD4+ cell count, higher HIV RNA, and non-infection
related NADC (see Table 1). Figure 1 shows cumulative
mortality after cancer diagnosis stratified by type of
cancer.
Conclusions
In the era of ART, unique independent predictors of
mortality among individuals with HIV and cancer were
level of immune suppression, degree of HIV RNA repli-
cation, and non-infection-related type of cancer. These
data highlight the need to improve prevention and man-
agement of NADC in this population.
Acknowledgements
These findings are presented on behalf of the CNICS. Funding for this study
was provided by NIAID and NCI.
This article has been published as part of Infectious Agents and Cancer
Volume 5 Supplement 1, 2010: Proceedings of the 12
th International
Conference on Malignancies in AIDS and Other Acquired
Immunodeficiencies (ICMAOI).The full contents of the supplement are
available online at http://www.biomedcentral.com/1750-9378/5?issue=S1.
Author details
1Division of Infectious Diseases, Northwestern University, Chicago, IL, USA.
2Department of Epidemiology, University of North Carolina at Chapel Hill,
Chapel Hill, NC, USA.
3Division of Allergy and Infectious Diseases, University
of Washington, Seattle, WA, USA.
4Division of Infectious Diseases, University
of Alabama at Birmingham, Birmingham, AL, USA.
Published: 11 October 2010
doi:10.1186/1750-9378-5-S1-A56
Cite this article as: Achenbach et al.: Mortality after cancer diagnosis
among HIV-infected individuals in the CFAR Network of Integrated
Clinical Systems (CNICS). Infectious Agents and Cancer 2010 5(Suppl 1):A56.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Figure 1 Mortality after cancer diagnosis for 918 HIV+ adults
by cancer type. Non-infection-related NADC is solid line, ADC is
dotted line, and infection-related NADC is dashed line.
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